Novel Tubular Biomarkers Predict Renal Progression in Type 2 Diabetes Mellitus: A Prospective Cohort Study.
Background.Tubulointerstitial injury is both a key feature of diabetic nephropathy and an important predictor of renal dysfunction. Novel tubular biomarkers related to renal injury in diabetic nephropathy could improve risk stratification and prediction.Methods.A total of 303 type 2 diabetic patients were followed up. The baseline urine values of cystatin-C to creatinine ratio (UCCR), angiotensinogen to creatinine ratio (UANG), NGAL to creatinine ratio (UNGAL), and KIM-1 to creatinine ratio (UKIM-1) were measured. The primary outcome was a decline in estimated GFR of ≥25% yearly from baseline.Results.Urine tubular biomarkers of UCCR, UANG, UNGAL, and UKIM-1 were significantly higher according to the degree of albuminuria and all were significantly higher among patients with rapid decline in estimated GFR of ≥25% yearly from baseline. All biomarkers predicted primary outcomes with ROC for UCCR of 0.72; 95% CI 0.64-0.79, for UANG of 0.71; 95% CI 0.63-0.79, for UNGAL of 0.64; 95% CI 0.56-0.72, and for UKIM-1 of 0.71; 95% CI 0.63-0.79. Using multivariate Cox regression analysis, the number of patients with rapid renal progression was higher among those in the upper quartiles of all biomarkers than in those in the lower quartiles.Conclusions. Type 2 diabetic patients with high levels of urine tubular biomarkers had a more rapid decline in renal function.
Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Bancha
0000-0002-8881-0942
B
Satirapoj
Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Kasemsan
K
Aramsaowapak
Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Theerasak
T
Tangwonglert
Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Ouppatham
O
Supasyndh
Am J Kidney Dis. 2012 Aug;60(2):233-40
22542304
Adv Chronic Kidney Dis. 2012 Mar;19(2):93-100
22449346
Cytokine Growth Factor Rev. 2011 Jun;22(3):131-9
21757394
Diabetes Care. 2013 Mar;36(3):656-61
23093662
Clin Biochem. 2016 Feb;49(3):232-6
26519090
Clin Kidney J. 2014 Aug;7(4):354-60
25852909
Exp Ther Med. 2014 Sep;8(3):887-892
25120619
Kidney Int. 2002 Jul;62(1):237-44
12081583
Endocrine. 2009 Aug;36(1):45-51
19390997
J Am Soc Nephrol. 2004 Dec;15(12 ):3073-82
15579510
Diabetes Care. 2015 Jun;38(6):1130-7
25784666
Clin Lab. 2012;58(7-8):659-71
22997966
J Am Soc Nephrol. 2014 Oct;25(10 ):2177-86
24904085
Ann Intern Med. 2009 May 5;150(9):604-12
19414839
Acta Endocrinol (Copenh). 1982 Aug;100(4):550-5
6812342
J Am Soc Nephrol. 2004 Jul;15(7):1805-15
15213268
J Am Soc Nephrol. 2006 Nov;17(11):2964-6
17035605
Am J Kidney Dis. 2015 Jul;66(1 Suppl 1):Svii, S1-305
26111994
Diabetes Res Clin Pract. 2012 Jul;97(1):71-6
22402306
Endocrine. 2012 Feb;41(1):82-8
21779943
Kidney Res Clin Pract. 2014 Sep;33(3):121-31
26894033
Diabetes. 1994 Nov;43(11):1358-64
7926312
Kidney Int. 2004 Jun;65(6):2153-60
15149328
Scand J Clin Lab Invest. 2009;69(1):138-44
18846477
J Am Soc Nephrol. 2003 Oct;14 (10 ):2534-43
14514731
Exp Toxicol Pathol. 2013 Jul;65(5):615-22
22795897
Kidney Int. 2016 Feb;89(2):459-67
26509588
Kidney Blood Press Res. 2008;31(4):255-8
18600028
Diabetes Res Clin Pract. 2012 Aug;97(2):251-7
22440044
Histopathology. 1995 Jun;26(6):559-64
7665147
Adv Chronic Kidney Dis. 2005 Apr;12(2):177-86
15822053